Jeffrey Barnes

14PUBLICATIONS

134CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersChemotherapyMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 30, 2026

Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Oct 31, 2025

A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

J Erika Haydu, Robert A Redd, Matthew M Lei

|Jul 15, 2025

Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy.

Leon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson

|Jun 17, 2025

Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas.

Josie G Ford, Min Jung Koh, Alexandra W Lenart

|Mar 03, 2025

A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis.

Pablo Mozas, Romain Ould Ammar, Loïc Chartier

|Jan 09, 2025

Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study.

Max S Topp, Matthew Matasar, John N Allan

Pageof 3

Frequent Collaborators

8 joint publications

Jeremy S Abramson

6 joint publications

Patrick Connor Johnson

Jacob D Soumerai

Ann S LaCasce

Josie Germain Ford

Min Jung Koh

Kusha Chopra

Robert Redd

Salvia Jain

Khyati Maulik Kariya

Frequent Collaborators

8 joint publications

Jeremy S Abramson

6 joint publications

Patrick Connor Johnson

4 joint publications

Jacob D Soumerai

3 joint publications

Ann S LaCasce